Pilot Study on the Adaptation and Tolerance of Essilor® Myopia-control Spectacle Lenses (NCT07340931) | Clinical Trial Compass
RecruitingNot Applicable
Pilot Study on the Adaptation and Tolerance of Essilor® Myopia-control Spectacle Lenses
France50 participantsStarted 2026-01-20
Plain-language summary
This observational pilot study aims to evaluate the adaptation and tolerance of Essilor® Stellest® myopia-control spectacle lenses in children with progressive myopia. The objective is to assess real-life compliance and comfort during lens wear, as these factors are essential for long-term therapeutic adherence and overall visual health outcomes
Who can participate
Age range
6 Years – 16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 6 to 16 years with progressive myopia.
* Spherical equivalent ≤ -0.50 D under cycloplegia and presence of at least one risk factor (age \< 10 years, progression ≥ 0.50 D/year, axial length increase ≥ 0.2 mm/year, high myopia ≤ -6.00 D and/or axial length ≥ 26 mm, both parents myopic, at least one parent highly myopic, or Asian origin).
* Patient covered by the French social security system.
* Patient and legal guardians providing oral non-opposition to participate in the study.
Exclusion Criteria:
* Patients with strabismus, amblyopia, or syndromic myopia
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this trial is not yet recruiting, when do you expect it to open, and would it make sense for us to revisit this option once enrollment actually begins?
2This is listed as a pilot study — what does that mean for how much is already known about the safety and comfort of the Essilor Stellest 2.0 lenses, compared to standard myopia-control glasses my child could get right now?
3The trial is specifically measuring how well children adapt to and tolerate these new lenses — does that mean there could be an adjustment period with discomfort or vision disturbances we should be prepared for?
4Before considering this trial, should we talk about what standard myopia-control options, like regular Stellest lenses or orthokeratology, are already available and whether one of those might be a better starting point?
5What would participating in this study actually require in terms of follow-up visits, and is that level of commitment realistic for our family's schedule given that it hasn't even started enrolling yet?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Adaptation and tolerance of Essilor® Stellest® 2.0 myopia-control spectacle lenses
Timeframe: At 6 months after initiation of lens wear